藐视
发表于 2025-3-23 10:09:20
Molecular Biology of Secondary Metabolism: Case Study for , Plantsiterpene saponin, glycyrrhizin, which is a well-known sweetener as well as a pharmaceutical. We are using . (common licorice) as a model plant to elucidate the regulation of triterpene biosynthesis in higher plants. Cultured cells of ... do not produce glycyrrhizin but produce two structurally diffe
乐器演奏者
发表于 2025-3-23 14:18:15
http://reply.papertrans.cn/83/8230/822947/822947_12.png
RADE
发表于 2025-3-23 22:06:34
http://reply.papertrans.cn/83/8230/822947/822947_13.png
FOLD
发表于 2025-3-24 00:52:00
Biotechnology of the Rhizosphereizosphere: beneficial microorganisms (termed . or the plant growth-promoting rhizosphere bacteria) that inhabit it. After that, several biotechnological approaches for management of the rhizosphere will be presented. These approaches relate to environment friendly agricultural practices, the product
Tincture
发表于 2025-3-24 04:21:16
Plants as Sources of Energyrom light-catalyzed carbon dioxide fixation via photosynthesis. This stored carbon from plants is available in oil and coal deposits that can be used as energy sources known as petrofuels. Living plants or plant residues can be used to generate biofuels such as methane from methane generators, wood
senile-dementia
发表于 2025-3-24 09:35:56
Interactions of Bioactive Plant Metabolites: Synergism, Antagonism, and Additivitythat matter, two or more bioactive plant compounds, will either interact in some way or fail to interact. If an interaction produces an effect greater than that expected for each individual drug, the interaction is termed synergistic. If the effect is less than expected, it is termed antagonistic. I
Palpate
发表于 2025-3-24 11:46:20
http://reply.papertrans.cn/83/8230/822947/822947_17.png
Rotator-Cuff
发表于 2025-3-24 16:16:06
http://reply.papertrans.cn/83/8230/822947/822947_18.png
Interregnum
发表于 2025-3-24 19:11:35
http://reply.papertrans.cn/83/8230/822947/822947_19.png
exigent
发表于 2025-3-25 02:47:37
Risks Involved in the Use of Herbal Products inadequate testing of the herbal product in clinical trials; failure to provide the stated amounts of active constituents; contraindications between known herbs and synthetic prescription drugs used to treat the same disease; overdosing or underdosing; contamination of herbal preparations with path